论文部分内容阅读
目的观察参麦注射液联合倍他啶治疗慢性脑供血不足的临床疗效。方法对100例慢性脑供血不足给予参麦注射液、倍他啶治疗,比较治疗前后脑血流动力学改善情况及临床疗效。结果治疗后患者症状及脑血流动力学明显改善,临床疗效明显(P<0.05或P<0.01)。结论参麦注射液联合倍他啶治疗慢性脑供血不足疗效显著。
Objective To observe the clinical efficacy of Shenmai injection combined with Betazolidine in the treatment of chronic cerebral hypoperfusion. Methods 100 cases of chronic cerebral hypoperfusion were given Shenmai Injection and Betadine, and the improvement of cerebral hemodynamics and clinical curative effect were compared before and after treatment. Results After treatment, the symptoms and cerebral hemodynamics were significantly improved, and the clinical effect was obvious (P <0.05 or P <0.01). Conclusion Shenmai injection combined with betamethasone treatment of chronic cerebral insufficiency has a significant effect.